Home » Newsletters » The Carlat Hospital Psychiatry Report

The Carlat Hospital Psychiatry Report

Psychiatric Emergencies (Jan/Feb/Mar) | 2021

View Archived Issues

CME Post-Test - Psychiatric Emergencies, CHPR, Jan/Feb/Mar 2021

April 12, 2021

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More

Introducing The Carlat Hospital Psychiatry Report (CHPR)

April 12, 2021

Welcome to the inaugural issue of CHPR—our fourth CME newsletter. Unlike our other newsletters, which are focused on outpatient practice, the focus of CHPR is on hospital psychiatry, including inpatient units, emergency rooms, and consult liaison work. Read More

Intranasal Esketamine: New Hope for Suicidal Patients?

April 12, 2021

Daniel Carlat, MD

Imagine a drug that resolves depression within hours in people at imminent risk of suicide. Esketamine may be such a drug — but is it a miracle cure? Here we look at the data and discuss the pros and cons of this new treatment. Read More

Serotonin Syndrome Versus NMS

April 12, 2021

Laura Tormoehlen, MD

Dr. Laura Tormoehlen discusses the management of neuroleptic malignant syndrome and serotonin syndrome and summarizes how to distinguish between these acute conditions. Read More

Deliberate Foreign Body Ingestion

April 12, 2021

Adrienne Grzenda, MD, PhD.

Why would anyone deliberately swallow a nondigestible object? What items require emergent removal, vs simple monitoring? And how can you help patients who repeatedly swallow foreign bodies? Read More

Combination Treatment for Schizophrenia

April 12, 2021

T. Scott Stroup, MD, MPH

Dr. T. Scott Stroup, Professor of Psychiatry at Columbia University, reveals surprising findings from his research on the use of adjunctive medications for schizophrenia. Read More

Antipsychotic Dosing: How High?

April 12, 2021

Paul Barkopoulos, MD.

How high should we go when dosing antipsychotics in schizophrenia? A recent meta-analysis of 68 studies examined dose-response relationships in randomized controlled trials of antipsychotic medications for schizophrenia and schizoaffective disorder. Read More

Welcoming Our New Editor-in-Chief

April 12, 2021

We’re pleased to introduce Victoria Hendrick, MD, as CHPR’s editor-in-chief. Dr. Hendrick is a clinical professor at the David Geffen School of Medicine at UCLA and the director of inpatient psychiatry at Olive View UCLA Medical Center, where she carries a caseload of patients and teaches and supervises medical students and psychiatry residents. Read More